Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Updated: Oct 11, 2026
Mara Goldstein's Stock Ratings
Mizuho Analyst
Mara Goldstein is an analyst at Mizuho. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends.
Overall Average Return
15.9%
Smart Score
Overall Average Return Percentile
71st
Number of Ratings
73
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 08/18/2026 | IOVA | Buy Now | Iovance Biotherapeutics | $14.60 | -24.64% | $10 → $11 | Maintains | Outperform | Get Alert | |
| 03/24/2026 | KURA | Buy Now | Kura Oncology | $10.61 | 135.63% | $30 → $25 | Maintains | Outperform | Get Alert | |
| 05/19/2025 | KURA | Buy Now | Kura Oncology | $10.61 | 182.75% | $32 → $30 | Maintains | Outperform | Get Alert | |
| 05/12/2025 | IOVA | Buy Now | Iovance Biotherapeutics | $14.60 | -31.49% | $30 → $10 | Maintains | Outperform | Get Alert | |
| 04/09/2025 | VSTM | Buy Now | Verastem | $8.48 | -5.62% | $9 → $8 | Maintains | Outperform | Get Alert | |
| 12/19/2024 | VSTM | Buy Now | Verastem | $8.48 | 6.18% | $7 → $9 | Maintains | Outperform | Get Alert | |
| 01/31/2024 | KURA | Buy Now | Kura Oncology | $10.61 | 201.6% | $26 → $32 | Maintains | Buy | Get Alert | |
| 01/30/2024 | RCUS | Buy Now | Arcus Biosciences | $24.41 | 72.06% | $51 → $42 | Maintains | Buy | Get Alert | |
| 01/22/2024 | XNCR | Buy Now | Xencor | $24.63 | 103% | $59 → $50 | Maintains | Buy | Get Alert | |
| 12/22/2023 | SNDX | Buy Now | Syndax Pharmaceuticals | $17.75 | 153.52% | → $45 | Initiates | → Buy | Get Alert | |
| 12/22/2023 | KURA | Buy Now | Kura Oncology | $10.61 | 145.05% | → $26 | Initiates | → Buy | Get Alert | |
| 12/14/2023 | INCY | Buy Now | Incyte | $112.79 | -31.73% | $82 → $77 | Maintains | Neutral | Get Alert | |
| 11/29/2023 | ERAS | Buy Now | Erasca | $15.55 | -54.98% | $8 → $7 | Maintains | Buy | Get Alert | |
| 11/20/2023 | FATE | Buy Now | Fate Therapeutics | $2.17 | 268.66% | $12 → $8 | Maintains | Buy | Get Alert | |
| 11/20/2023 | LPTX | Buy Now | Leap Therapeutics | — | — | $20 → $12 | Maintains | Buy | Get Alert | |
| 10/03/2023 | RCUS | Buy Now | Arcus Biosciences | $24.41 | 108.93% | → $51 | Reiterates | Buy → Buy | Get Alert | |
| 09/15/2023 | IOVA | Buy Now | Iovance Biotherapeutics | $14.60 | 105.52% | → $30 | Reiterates | Buy → Buy | Get Alert | |
| 08/29/2023 | VSTM | Buy Now | Verastem | $8.48 | 324.71% | → $36 | Reiterates | Buy → Buy | Get Alert | |
| 08/23/2023 | RCUS | Buy Now | Arcus Biosciences | $24.41 | 108.93% | → $51 | Reiterates | Buy → Buy | Get Alert | |
| 08/07/2023 | NKTR | Buy Now | Nektar Therapeutics | $41.17 | -85.43% | → $6 | Reiterates | → Neutral | Get Alert | |
| 06/27/2023 | IOVA | Buy Now | Iovance Biotherapeutics | $14.60 | 105.52% | → $30 | Reiterates | Buy → Buy | Get Alert | |
| 06/16/2023 | CRVS | Buy Now | Corvus Pharma | $10.44 | -66.48% | → $3.5 | Reiterates | Neutral → Neutral | Get Alert | |
| 06/16/2023 | IOVA | Buy Now | Iovance Biotherapeutics | $14.60 | 105.52% | → $30 | Reiterates | Buy → Buy | Get Alert | |
| 06/15/2023 | VSTM | Buy Now | Verastem | $8.48 | 324.71% | $24 → $36 | Upgrade | Neutral → Buy | Get Alert | |
| 06/06/2023 | ERAS | Buy Now | Erasca | $15.55 | -48.55% | $9 → $8 | Maintains | Buy | Get Alert | |
| 05/09/2023 | NLTX | Buy Now | Neoleukin Therapeutics | — | — | $2 → $1.5 | Maintains | Neutral | Get Alert | |
| 05/03/2023 | INCY | Buy Now | Incyte | $112.79 | -27.3% | $95 → $82 | Maintains | Neutral | Get Alert | |
| 04/24/2023 | INAB | Buy Now | IN8bio | $1.33 | 802.26% | → $12 | Reiterates | → Buy | Get Alert | |
| 04/19/2023 | IMRX | Buy Now | Immuneering | $3.77 | 430.5% | $10 → $20 | Upgrade | Neutral → Buy | Get Alert | |
| 04/13/2023 | LPTX | Buy Now | Leap Therapeutics | — | — | → $2 | Reiterates | → Buy | Get Alert | |
| 04/10/2023 | MRK | Buy Now | Merck & Co | $146.31 | -11.15% | → $130 | Reiterates | → Buy | Get Alert | |
| 03/30/2023 | CRVS | Buy Now | Corvus Pharma | $10.44 | -66.48% | → $3.5 | Reiterates | → Neutral | Get Alert | |
| 03/30/2023 | ERAS | Buy Now | Erasca | $15.55 | -42.12% | → $9 | Initiates | → Buy | Get Alert | |
| 03/30/2023 | IMRX | Buy Now | Immuneering | $3.77 | 165.25% | → $10 | Initiates | → Neutral | Get Alert | |
| 03/30/2023 | VSTM | Buy Now | Verastem | $8.48 | -76.4% | → $2 | Initiates | → Neutral | Get Alert | |
| 03/28/2023 | CTMX | Buy Now | CytomX Therapeutics | $2.58 | -22.48% | $4 → $2 | Maintains | Neutral | Get Alert | |
| 03/24/2023 | TCRR | Buy Now | TCR2 Therapeutics | — | — | $20 → $1.72 | Downgrade | Buy → Neutral | Get Alert | |
| 03/17/2023 | MRK | Buy Now | Merck & Co | $146.31 | -11.15% | → $130 | Reiterates | → Buy | Get Alert | |
| 03/17/2023 | RCUS | Buy Now | Arcus Biosciences | $24.41 | 108.93% | → $51 | Reiterates | → Buy | Get Alert | |
| 03/17/2023 | LPTX | Buy Now | Leap Therapeutics | — | — | $3 → $2 | Maintains | Buy | Get Alert | |
| 03/08/2023 | AUTL | Buy Now | Autolus Therapeutics | $1.83 | 555.74% | $18 → $12 | Maintains | Buy | Get Alert | |
| 02/10/2023 | XNCR | Buy Now | Xencor | $24.63 | 139.55% | → $59 | Reiterates | → Buy | Get Alert | |
| 02/08/2023 | INCY | Buy Now | Incyte | $112.79 | -15.77% | $95 → $95 | Maintains | Neutral | Get Alert | |
| 01/27/2023 | LPTX | Buy Now | Leap Therapeutics | — | — | $6 → $3 | Maintains | Buy | Get Alert | |
| 11/15/2022 | NLTX | Buy Now | Neoleukin Therapeutics | — | — | $21 → $2 | Downgrade | Buy → Neutral | Get Alert | |
| 11/09/2022 | ADAP | Buy Now | Adaptimmune Therapeutics | — | — | → $9 | Upgrade | Neutral → Buy | Get Alert | |
| 07/07/2022 | CTMX | Buy Now | CytomX Therapeutics | $2.58 | 55.04% | $16 → $4 | Downgrade | Buy → Neutral | Get Alert | |
| 04/18/2022 | NKTR | Buy Now | Nektar Therapeutics | $41.17 | -85.43% | $8 → $6 | Maintains | Neutral | Get Alert | |
| 03/15/2022 | NKTR | Buy Now | Nektar Therapeutics | $41.17 | -80.57% | $35 → $8 | Downgrade | Buy → Neutral | Get Alert | |
| 10/04/2021 | LPTX | Buy Now | Leap Therapeutics | — | — | → $6 | Initiates | → Buy | Get Alert | |
| 10/04/2021 | EFTR | Buy Now | eFFECTOR Therapeutics | $0.00 | 9999900% | → $20 | Initiates | → Buy | Get Alert | |
| 09/14/2021 | KDMN | Buy Now | Kadmon Holdings | — | — | $13 → $9.5 | Downgrade | Buy → Neutral | Get Alert | |
| 08/24/2021 | INAB | Buy Now | IN8bio | $1.33 | 802.26% | → $12 | Initiates | → Buy | Get Alert | |
| 08/03/2021 | CRVS | Buy Now | Corvus Pharma | $10.44 | -66.48% | $4 → $3.5 | Maintains | Neutral | Get Alert | |
| 02/25/2021 | FATE | Buy Now | Fate Therapeutics | $2.17 | 4923.04% | $88 → $109 | Maintains | Buy | Get Alert | |
| 02/10/2021 | CRVS | Buy Now | Corvus Pharma | $10.44 | -61.69% | $7 → $4 | Downgrade | Buy → Neutral | Get Alert | |
| 11/11/2020 | KDMN | Buy Now | Kadmon Holdings | — | — | → $13 | Initiates | → Buy | Get Alert | |
| 06/19/2020 | AUTL | Buy Now | Autolus Therapeutics | $1.83 | 1211.48% | $18 → $24 | Maintains | Buy | Get Alert | |
| 06/18/2020 | NLTX | Buy Now | Neoleukin Therapeutics | — | — | → $21 | Initiates | → Buy | Get Alert | |
| 06/01/2020 | ADAP | Buy Now | Adaptimmune Therapeutics | — | — | $3 → $9 | Maintains | Neutral | Get Alert | |
| 04/22/2020 | ADAP | Buy Now | Adaptimmune Therapeutics | — | — | → $3 | Initiates | → Neutral | Get Alert | |
| 04/22/2020 | IOVA | Buy Now | Iovance Biotherapeutics | $14.60 | 317.89% | → $61 | Initiates | → Buy | Get Alert | |
| 04/22/2020 | AUTL | Buy Now | Autolus Therapeutics | $1.83 | 883.61% | → $18 | Initiates | → Buy | Get Alert | |
| 03/04/2020 | FTSV | Buy Now | Forty Seven | — | — | → $95.5 | Downgrade | Buy → Neutral | Get Alert | |
| 02/26/2020 | FATE | Buy Now | Fate Therapeutics | $2.17 | 1743.32% | $33 → $40 | Maintains | Buy | Get Alert | |
| 02/12/2020 | FTSV | Buy Now | Forty Seven | — | — | $37 → $53 | Maintains | Buy | Get Alert | |
| 01/03/2020 | INCY | Buy Now | Incyte | $112.79 | -29.96% | $98 → $79 | Downgrade | Buy → Neutral | Get Alert | |
| 12/30/2019 | FATE | Buy Now | Fate Therapeutics | $2.17 | 1420.74% | $27 → $33 | Reiterates | → Buy | Get Alert | |
| 12/10/2019 | FTSV | Buy Now | Forty Seven | — | — | $18 → $37 | Reiterates | → Buy | Get Alert | |
| 10/03/2019 | INCY | Buy Now | Incyte | $112.79 | -15.77% | → $95 | Initiates | → Buy | Get Alert | |
| 09/12/2019 | FTSV | Buy Now | Forty Seven | — | — | → $18 | Initiates | → Buy | Get Alert | |
| 09/12/2019 | CRVS | Buy Now | Corvus Pharma | $10.44 | -32.95% | → $7 | Initiates | → Buy | Get Alert | |
| 09/06/2019 | CYTK | Buy Now | Cytokinetics | $62.91 | -68.21% | $14 → $20 | Reiterates | → Overweight | Get Alert |
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investor Events
- Pre-market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2026 Benzinga | All Rights Reserved